,Name of Issuer,Title of Class,CUSIP,Value,SHRS OR SH,PRN AMT PRN,Investment Discretion,Voting Authority_Sole,Voting Authority_Shared,Voting Authority_None,Date,Period,Filing Manager,CIK
0,ABBVIE INC.,COM,00287Y109,725,10000,SH,SOLE,10000,0,0,2017-06-30,2017Q2,Sarissa Capital Management LP,0001577524
1,ADVAXIS INC,COM NEW,007624208,2201,339180,SH,SOLE,339180,0,0,2017-06-30,2017Q2,Sarissa Capital Management LP,0001577524
2,APRICUS BIOSCIENCES INC,COM NEW,03832V307,1636,1447906,SH,SOLE,1447906,0,0,2017-06-30,2017Q2,Sarissa Capital Management LP,0001577524
3,BIOGEN INC,COM,09062X103,104163,383858,SH,SOLE,383858,0,0,2017-06-30,2017Q2,Sarissa Capital Management LP,0001577524
4,BIOVERATIV INC,COM,09075r100,70098,1165000,SH,SOLE,1165000,0,0,2017-06-30,2017Q2,Sarissa Capital Management LP,0001577524
5,INNOVIVA INC,COM,45781M101,44681,3490705,SH,SOLE,3490705,0,0,2017-06-30,2017Q2,Sarissa Capital Management LP,0001577524
6,MEDICINES CO,COM,584688105,66593,1752000,SH,SOLE,1752000,0,0,2017-06-30,2017Q2,Sarissa Capital Management LP,0001577524
7,NOVELION THERAPEUTICS INC,COM NEW,67001K202,9460,1025000,SH,SOLE,1025000,0,0,2017-06-30,2017Q2,Sarissa Capital Management LP,0001577524
